SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.260+1.6%Oct 31 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: deeno who wrote (3426)12/10/2013 2:07:29 PM
From: scaram(o)uche1 Recommendation

Recommended By
seminole

   of 3576
 
One other thought.... there is something new in the world of FDA's role in drug development since the purchase of YMI by Gilead.... it's called "breakthrough designation". Given the results, Geron must have applied for this??

fda.gov

If so, approval might, for all I know, come at any time.

Would lead to sudden upside.

:-)

Good luck! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News